Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice

References

• Aggarwal S, Gurney AL. 2002. IL-17: prototype member of an emerging cytokine family. J Leukoc Bio 71:128.
   Google Scholar
• Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278:17036–17043.
   PubMed Web of Science ®Google Scholar
• Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. 1978. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:1277–1281.
   PubMed Web of Science ®Google Scholar
• Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C, Ceuppens JL. 2003. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 28:42–50.
   PubMed Web of Science ®Google Scholar
• Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20:5332–5341.
   PubMed Web of Science ®Google Scholar
• Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, Gurney AL. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276:1660–1664.
   PubMed Web of Science ®Google Scholar
• Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, Dowd P, Gurney AL, Wood WI. 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97:773–778.
   PubMed Web of Science ®Google Scholar
• Li YT, He B, Wang YZ. 2009. Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs. Inhal Toxicol 21:641–647.
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. 2009. Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888–898.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Prause O, Sjöstrand M, Laan M, Lötvall J, Lindén A. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170:4665–4672.
   PubMed Web of Science ®Google Scholar
• Motz GT, Eppert BL, Wesselkamper SC, Flury JL, Borchers MT. 2010. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. Am J Respir Crit Care Med 181:1223–1233.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee KS, Kim SR, Min KH, Choe YH, Moon H, Chae HJ, Yoo WH, Lee YC. 2009. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation. J Immunol 183:3259–3267.
   PubMed Web of Science ®Google Scholar
• Shen F, Zhao MW, He B, Pei F, Yao WZ. 2006. Observations on lung function and pathological changes of airway lung tissues in rats with different passive-smoking durations. Journal of Guiyang Medical College 31:247–250.
   Google Scholar
• Shen F, Zhao MW, He B, Wang YZ, Yao WZ. 2004a. [The levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma]. Zhonghua Nei Ke Za Zhi 43:888–890.
   PubMedGoogle Scholar
• Shen F, Zhao MW, He B, Yang JJ, Pei F, Wang YZ. 2004b. [The changes and significance of interleukin-17 in rat models of chronic obstructive pulmonary disease and asthma]. Zhonghua Jie He He Hu Xi Za Zhi 27:654–658.
   PubMedGoogle Scholar
• Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, Olsen H, Ruben SM, Knyazev I, Cho YH, Kao V, Wilkinson KA, Carrell JA, Ebner R. 2000. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 275:19167–19176.
   PubMed Web of Science ®Google Scholar
• Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. 1999. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 14:1015–1022.
   PubMed Web of Science ®Google Scholar
• Takehana Y, Hamano S, Kikuchi S, Komatsu H, Okegawa T, Ikeda S. 1990. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness. Jpn J Pharmacol 52:621–630.
   PubMedGoogle Scholar
• Wright JL, Churg A. 2002. Animal models of cigarette smoke-induced COPD. Chest 122:301–306.
   PubMed Web of Science ®Google Scholar
• Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. 1995. Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483–5486.
   PubMed Web of Science ®Google Scholar